FACEPHI BIOMETRIA SA (ALPHI.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ALPHI - ES0105029005 - Common Stock
2.59 EUR
-0.01 (-0.38%)
Overall ALPHI gets a fundamental rating of 3 out of 10. We evaluated ALPHI against 119 industry peers in the Software industry. ALPHI may be in some trouble as it scores bad on both profitability and health. ALPHI is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year ALPHI has reported negative net income.
- In the past year ALPHI had a positive cash flow from operations.
- ALPHI had negative earnings in 4 of the past 5 years.
- In multiple years ALPHI reported negative operating cash flow during the last 5 years.
1.2 Ratios
- The Return On Assets of ALPHI (-19.65%) is worse than 84.87% of its industry peers.
- With a Return On Equity value of -46.24%, ALPHI is not doing good in the industry: 83.19% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.65% | ||
| ROE | -46.24% | ||
| ROIC | N/A |
ROA(3y)-7.9%
ROA(5y)-7.67%
ROE(3y)-20.34%
ROE(5y)-18.76%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ALPHI has a worse Gross Margin (53.83%) than 69.75% of its industry peers.
- ALPHI's Gross Margin has declined in the last couple of years.
- The Profit Margin and Operating Margin are not available for ALPHI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 53.83% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.32%
GM growth 5Y-11.24%
2. Health
2.1 Basic Checks
- ALPHI does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, ALPHI has more shares outstanding
- ALPHI has more shares outstanding than it did 5 years ago.
- ALPHI has a better debt/assets ratio than last year.
2.2 Solvency
- ALPHI has an Altman-Z score of 1.47. This is a bad value and indicates that ALPHI is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of ALPHI (1.47) is worse than 64.71% of its industry peers.
- ALPHI has a debt to FCF ratio of 5.75. This is a neutral value as ALPHI would need 5.75 years to pay back of all of its debts.
- The Debt to FCF ratio of ALPHI (5.75) is comparable to the rest of the industry.
- ALPHI has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
- ALPHI has a better Debt to Equity ratio (0.04) than 80.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 5.75 | ||
| Altman-Z | 1.47 |
ROIC/WACCN/A
WACC9.38%
2.3 Liquidity
- ALPHI has a Current Ratio of 1.00. This is a normal value and indicates that ALPHI is financially healthy and should not expect problems in meeting its short term obligations.
- ALPHI's Current ratio of 1.00 is on the low side compared to the rest of the industry. ALPHI is outperformed by 69.75% of its industry peers.
- A Quick Ratio of 1.00 indicates that ALPHI may have some problems paying its short term obligations.
- ALPHI has a Quick ratio of 1.00. This is in the lower half of the industry: ALPHI underperforms 68.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
- The earnings per share for ALPHI have decreased strongly by -11.54% in the last year.
- The Revenue has grown by 11.11% in the past year. This is quite good.
- ALPHI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.76% yearly.
EPS 1Y (TTM)-11.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
Revenue 1Y (TTM)11.11%
Revenue growth 3Y30.13%
Revenue growth 5Y28.76%
Sales Q2Q%8.33%
3.2 Future
- Based on estimates for the next years, ALPHI will show a very strong growth in Earnings Per Share. The EPS will grow by 29.14% on average per year.
- Based on estimates for the next years, ALPHI will show a quite strong growth in Revenue. The Revenue will grow by 19.34% on average per year.
EPS Next Y104%
EPS Next 2Y50.67%
EPS Next 3YN/A
EPS Next 5Y29.14%
Revenue Next Year25.74%
Revenue Next 2Y24.47%
Revenue Next 3Y19.64%
Revenue Next 5Y19.34%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ALPHI. In the last year negative earnings were reported.
- ALPHI is valuated quite expensively with a Price/Forward Earnings ratio of 28.21.
- The rest of the industry has a similar Price/Forward Earnings ratio as ALPHI.
- ALPHI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.32, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 28.21 |
4.2 Price Multiples
- ALPHI's Enterprise Value to EBITDA is on the same level as the industry average.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALPHI is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 42.26 | ||
| EV/EBITDA | 48.18 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as ALPHI's earnings are expected to grow with 50.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.67%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for ALPHI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EPA:ALPHI (1/22/2026, 7:00:00 PM)
2.59
-0.01 (-0.38%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-20 2025-10-20
Earnings (Next)04-27 2026-04-27
Inst Owners27.19%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap66.77M
Revenue(TTM)30.00M
Net Income(TTM)-7.86M
Analysts82.5
Price Target3.46 (33.59%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.88%
PT rev (3m)7.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-17.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 28.21 | ||
| P/S | 2.23 | ||
| P/FCF | 42.26 | ||
| P/OCF | 8.71 | ||
| P/B | 3.93 | ||
| P/tB | 13.35 | ||
| EV/EBITDA | 48.18 |
EPS(TTM)-0.29
EYN/A
EPS(NY)0.09
Fwd EY3.54%
FCF(TTM)0.06
FCFY2.37%
OCF(TTM)0.3
OCFY11.49%
SpS1.16
BVpS0.66
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.65% | ||
| ROE | -46.24% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 53.83% | ||
| FCFM | 5.27% |
ROA(3y)-7.9%
ROA(5y)-7.67%
ROE(3y)-20.34%
ROE(5y)-18.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.32%
GM growth 5Y-11.24%
F-Score5
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 5.75 | ||
| Debt/EBITDA | 0.48 | ||
| Cap/Depr | 101.67% | ||
| Cap/Sales | 20.3% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 485.44% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 1.47 |
F-Score5
WACC9.38%
ROIC/WACCN/A
Cap/Depr(3y)134.94%
Cap/Depr(5y)175.33%
Cap/Sales(3y)22.27%
Cap/Sales(5y)23.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
EPS Next Y104%
EPS Next 2Y50.67%
EPS Next 3YN/A
EPS Next 5Y29.14%
Revenue 1Y (TTM)11.11%
Revenue growth 3Y30.13%
Revenue growth 5Y28.76%
Sales Q2Q%8.33%
Revenue Next Year25.74%
Revenue Next 2Y24.47%
Revenue Next 3Y19.64%
Revenue Next 5Y19.34%
EBIT growth 1Y37.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year168.63%
EBIT Next 3Y52.17%
EBIT Next 5Y44.47%
FCF growth 1Y110.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y164.15%
OCF growth 3YN/A
OCF growth 5YN/A
FACEPHI BIOMETRIA SA / ALPHI.PA FAQ
What is the fundamental rating for ALPHI stock?
ChartMill assigns a fundamental rating of 3 / 10 to ALPHI.PA.
What is the valuation status for ALPHI stock?
ChartMill assigns a valuation rating of 3 / 10 to FACEPHI BIOMETRIA SA (ALPHI.PA). This can be considered as Overvalued.
What is the profitability of ALPHI stock?
FACEPHI BIOMETRIA SA (ALPHI.PA) has a profitability rating of 1 / 10.
What is the financial health of FACEPHI BIOMETRIA SA (ALPHI.PA) stock?
The financial health rating of FACEPHI BIOMETRIA SA (ALPHI.PA) is 3 / 10.